VOGLITOR R 1/0.2MG (Repaglinide (1mg) + Voglibose (0.2mg))

Voglitor R 1/0.2 Tablet is a therapeutic combination designed specifically for individuals managing type 2 diabetes mellitus. This formulation aids in regulating elevated blood glucose levels that can occur after meals, particularly when other medications and dietary restrictions have proven insufficient in controlling high blood sugar. Administering this medication should be done immediately following meals. The appropriate dosage will be determined by your healthcare provider, and it is crucial to adhere to their guidance without discontinuing the medication independently, as doing so could lead to a rise in blood sugar levels. This increase poses serious health risks, including potential kidney damage and vision loss. In the event of a missed dose, it is important not to take it between meals; instead, wait until the next meal to take the missed dose. Avoid compensating for a missed dose by taking an extra dose. This medication is intended to be part of a comprehensive treatment strategy that encompasses a balanced diet, consistent physical activity, and weight management, as recommended by your physician. While many individuals may experience adverse effects such as gas, diarrhea, stomach discomfort, low blood sugar, and skin rashes, these are typically brief and resolve on their own. However, if any side effects persist or cause concern, it is advisable to seek guidance from your healthcare provider. Regular monitoring of blood sugar levels is essential while using this medication. Prior to initiating treatment, it is important to inform your healthcare provider of any existing kidney or liver conditions, urinary tract infections, or if you are taking diuretics. Pregnant or breastfeeding individuals should consult their physician before starting this medication. Additionally, it is recommended to limit alcohol consumption while using this medication, as it may elevate the risk of certain side effects.